BioSpace News Archive

GenapSys Inc. (GenapSys), the company behind the world’s first highly accurate, affordable, and accessible gene sequencer, today announced it has named Jason Myers as its Chief Executive Officer, effective February 15, 2021

Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces an update to the configuration of the T-SPOT Discovery SARS-CoV-2 kit.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announces today the signing of a Master Sales Agreement with Community Shield LLC of Sheridan Wyoming to distribute its science-based nutraceutical line of products.

EmPOWERed Health program aims to educate and inspire people to be more proactive in their health and in the prevention and treatment of cancer

Sinclair Research, a leading provider of nonclinical contract research services, today announced its new virtual audit capabilities, allowing clients worldwide to conduct comprehensive vendor qualifications, facility audits and tours remotely.

Ambu Inc. the world leader in single-use endoscopes, announced that it has been granted national single-use endoscopy contract expansions with two major U.S. Group Purchasing Organizations.

Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, announced today three abstracts featuring its PSMA-targeted pipeline of product candidates have been selected for poster presentations at the upcoming 2021 American Society for Clinical Oncology Genitourinary

Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Thursday, February 11, at 4:00 p.m. CT, as a virtual meeting.

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company progressing Nano-Pulse Stimulation ™ (NPS ™ ) technology, today announced that it has filed a prospectus supplement with the Securities and Exchange Commission (“SEC”), under which it may offer and sell shares of its common stock (the “Shares”) having an aggregate offering price of up to $60,000,000

Nutrition industry content leaders Trust Transparency Center and Nutraceutic are pleased to announce the launch of a three-day interactive conference providing the latest in cutting edge science to help drive microbiom